全文获取类型
收费全文 | 1909篇 |
免费 | 88篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 44篇 |
妇产科学 | 20篇 |
基础医学 | 213篇 |
口腔科学 | 12篇 |
临床医学 | 161篇 |
内科学 | 418篇 |
皮肤病学 | 44篇 |
神经病学 | 61篇 |
特种医学 | 141篇 |
外科学 | 295篇 |
综合类 | 266篇 |
预防医学 | 83篇 |
眼科学 | 18篇 |
药学 | 107篇 |
中国医学 | 2篇 |
肿瘤学 | 114篇 |
出版年
2022年 | 15篇 |
2021年 | 24篇 |
2020年 | 13篇 |
2019年 | 28篇 |
2018年 | 22篇 |
2017年 | 18篇 |
2016年 | 34篇 |
2015年 | 50篇 |
2014年 | 41篇 |
2013年 | 52篇 |
2012年 | 55篇 |
2011年 | 64篇 |
2010年 | 71篇 |
2009年 | 67篇 |
2008年 | 61篇 |
2007年 | 87篇 |
2006年 | 90篇 |
2005年 | 68篇 |
2004年 | 75篇 |
2003年 | 53篇 |
2002年 | 44篇 |
2001年 | 33篇 |
2000年 | 31篇 |
1999年 | 49篇 |
1998年 | 49篇 |
1997年 | 58篇 |
1996年 | 60篇 |
1995年 | 39篇 |
1994年 | 42篇 |
1993年 | 23篇 |
1992年 | 44篇 |
1991年 | 38篇 |
1990年 | 38篇 |
1989年 | 44篇 |
1988年 | 47篇 |
1987年 | 36篇 |
1986年 | 33篇 |
1985年 | 28篇 |
1984年 | 30篇 |
1983年 | 21篇 |
1982年 | 24篇 |
1981年 | 16篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1976年 | 13篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1973年 | 14篇 |
1971年 | 13篇 |
1969年 | 16篇 |
排序方式: 共有2012条查询结果,搜索用时 15 毫秒
1.
2.
3.
Malignant hyperthermia is one of the most devastating crises encountered in anaesthesia and it frequently occurs unexpectedly. Although malignant hyperthermia develops in young individuals (mean age approximately 22 years), older people can also be affected. The case of a 41-year-old woman with a history of several previously uneventful general anaesthetics is described. She developed the complete symptomatology of malignant hyperthermia triggered by halothane anaesthesia, with tachycardia, cardiac arrhythmia, cyanosis, combined respiratory and metabolic acidosis and hyperpyrexia. Because treatment with dantrolene and hyperventilation with 100% O2 was started immediately, the symptoms of malignant hyperthermia were stopped within a short time. It should always be remembered, that the life threatening crises which can be caused by malignant hyperthermia can occur at any age and even after several uneventful anaesthetics. 相似文献
4.
E.K. Lavu FRCPA M. Nelson M.Sc PhD H.J. Popp AAIMS BA J. Gibson FRCP FRCPA PhD H. Kronenberg DCP FRCP FRCPA FRCPath H. Pearson FAIMS A. Child FRCOG 《The Australian & New Zealand journal of obstetrics & gynaecology》1997,37(2):180-183
Summary: regnant women who attended antenatal clinics at King George V Hospital, the Birth Centre or were referred by obstetricians from February to July. 1996 were screened for the platelet antigen HPA-la by flow cytometry. Forty out of 2300 (1.7%) were found to be negative for this antigen . Of the 28 women followed throughout their pregnancy, none developed antibody to HPA-la. Platelet counts performed on samples from 17 babies born to 17 of these mothers were all normal. This study proves the simplicity and rapidity of flow cytometry for platelet antigen screening. The results were comparable with the Solid Phase Red Cell Adherence (SPRCA) method and with PCR. The lack of a plentiful supply of specific antibody and the rarity of fetomaternai alloimmune thrombocytopenia (FMAIT) argue against the introduction of routine screening for maternal HPA-la status at the present time. 相似文献
5.
6.
7.
Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643 总被引:7,自引:1,他引:6
Conway James G.; Tomaszewski Konrad E.; Olson Michael J.; Cattley Russell C.; Marsman Daniel S.; Popp James A. 《Carcinogenesis》1989,10(3):513-519
Quantitative comparisons of the time course of biochemical andmorphological changes induced by peroxisome proliferators resultingin low and high incidences of hepatic cancer have not been conductedpreviously under bioassay conditions. [4-Chloro-6-(2,3 xylidino)-2-pyrimidyl-thio]aceticacid (Wy-14,643) at 0.1% in the diet produced a much higherincidence of hepatic cancer in male rats than 1.2% di(2-ethylhexyl)phthalate(DEHP) in the diet. Both diets, however, caused similar degreesof peroxisome proliferation. To investigate this differencein carcinogenicity, H2O2-detoxification mechanisms and indicesof oxidative damage were evaluated in male F-344 rats fed 1.2%DEHP or 0.1% Wy-14,643 for up to one year. DEHP or Wy-14,643treatment increased hepatic catalase activity 25% from 8 to365 days. DEHP or Wy-14,643 treatment decreased hepatic glutathioneperoxidase activity by 50% from 8 to 365 days. Glutathione concentrationswere not affected by 151 days of DEHP or Wy-14,643 feeding.The similar effects of DEHP and Wy on H2O2 detoxification enzymesand glutathione concentrations suggests that these factors arenot responsible for the widely different carcinogenicities ofWy-14,643 and DEHP. Hepatic vitamin E concentrations were 50%lower in rats receiving Wy-14,643 for 151 days as compared torats fed DEHP or control diets. Lipofuscin, which was containedwithin lysosomes, was increased 3-fold after 39 days of DEHPand remained at this level up to 365 days of treatment. In comparison,lipofuscin was increased 4-fold after 18 days of Wy-14,643 andcontinued to accumulate in a linear manner reaching values 30-foldover controls after 365 days of treatment. DEHP treatment for39365 days increased the activities of the lysosomalenzymes -fucosidase, ß-galactosidase and N-acetylglucosaminidase50100%. The same enzyme activities were increased 4-foldafter 39365 days of Wy-14,643. Lysosomal cathepsin Bactivity was unchanged by DEHP but doubled by 151 and 365 daysof Wy-14,643. Acid phosphatase activity was unchanged by DEHPbut increased by 50% after 151 and 365 days of Wy-14, 643. Inaddition, conjugated dienes were increased (45%) only in ratsreceiving Wy-14,643 for 151 and 365 days. These data show forthe first time that the magnitude and time course of lipofuscindeposition, induction of lysosomal enzymes and conjugated dieneaccumulation, is correlated closely with the degree of carcinogenicity.Wy-14,643-induced decreases in hepatic vitamin E concentrationscould contribute to the observed accumulation of conjugateddienes at later time points. The data suggest that lipofuscinaccumulation is an early biomarker that is quantitatively predictiveof the carcinogenicity of the peroxisome proliferators DEHPand Wy-14,643. 相似文献
8.
9.
Mahadevaiah SK; Odorisio T; Elliott DJ; Rattigan A; Szot M; Laval SH; Washburn LL; McCarrey JR; Cattanach BM; Lovell-Badge R; Burgoyne PS 《Human molecular genetics》1998,7(4):715-727
An RNA-binding motif (RBM) gene family has been identified on the human Y
chromosome that maps to the same deletion interval as the 'azoospermia
factor' (AZF). We have identified the homologous gene family (Rbm) on the
mouse Y with a view to investigating the proposal that this gene family
plays a role in spermatogenesis. At least 25 and probably >50 copies of
Rbm are present on the mouse Y chromosome short arm located between Sry and
the centromere. As in the human, a role in spermatogenesis is indicated by
a germ cell-specific pattern of expression in the testis, but there are
distinct differences in the pattern of expression between the two species.
Mice carrying the deletion Yd1, that maps to the proximal Y short arm, are
female due to a position effect resulting in non-expression of Sry ;
sex-reversing such mice with an Sry transgene produces males with a high
incidence of abnormal sperm, making this the third deletion interval on the
mouse Y that affects some aspect of spermatogenesis. Most of the copies of
Rbm map to this deletion interval, and the Yd1males have markedly reduced
Rbm expression, suggesting that RBM deficiency may be responsible for, or
contribute to, the abnormal sperm development. In man, deletion of the
functional copies of RBM is associated with meiotic arrest rather than
sperm anomalies; however, the different effects of deletion are consistent
with the differences in expression between the two species.
相似文献
10.